Evidence map›Paper›PMID 23195524›Full record

ArticleThe Journal of allergy and clinical immunology2012

The long-acting β-adrenergic agonist controversy in asthma: troublesome times!

Stanley J Szefler, William W Busse

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in The Journal of allergy and clinical immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Stanley J Szefler
William W Busse

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
EARLY INTERVENTION IN CHILDHOOD ASTHMAU10HL064288 · NHLBI · NATIONAL JEWISH HEALTH · PI SZEFLER, STANLEY J. · 1999 to 2008
$6.7M
Project 3: Environmental Determinants of Host DefenseP01ES018181 · NIEHS · NATIONAL JEWISH HEALTH · PI SCHWARTZ, DAVID ALBERT · 2009 to 2013
$5.7M
Clinical Centers for the NHLBI Asthma Network (AsthmaNet)U10HL098075 · NHLBI · NATIONAL JEWISH HEALTH · PI SZEFLER, STANLEY J., WECHSLER, MICHAEL E · 2009 to 2015
$5.1M
STEROID AND TARGET CELL FOCUS IN THE TREATMENT OF ASTHMAU10HL051834 · NHLBI · NATIONAL JEWISH HEALTH · PI MARTIN, RICHARD J · 1993 to 2002
$2.3M
CAMP Contiunation Study/Phase 3U01HL075416 · NHLBI · NATIONAL JEWISH HEALTH · PI SZEFLER, STANLEY J. · 2003 to 2010
$1.4M
Progression of Airway Obstruction in Childhood AsthmaR21HL087811 · NHLBI · NATIONAL JEWISH HEALTH · PI SZEFLER, STANLEY J. · 2008 to 2009
$429k
NCRR NIH HHS 1 UL1 RR025780NHLBI NIH HHS HL-51834NHLBI NIH HHS HL-64288NHLBI NIH HHS HL-75416NHLBI NIH HHS HL-87811NHLBI NIH HHS HL-98075NIAID NIH HHS AI-90052NIEHS NIH HHS ES-18181
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Epigenesis, GeneticAnimalsAsthmaHumansTh2 CellsT-Lymphocyte Subsets

Identifiers

PMID23195524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.